We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.27%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$14B
AUM Growth
+$764M
Cap. Flow
-$53.9M
Cap. Flow %
-0.38%
Top 10 Hldgs %
18.91%
Holding
386
New
14
Increased
92
Reduced
193
Closed
14

Top Sells

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$77.8M
2
COST icon
Costco
COST
+$64.6M
3
DOC
PHYSICIANS REALTY TRUST
DOC
+$62.5M
4
OMC icon
Omnicom Group
OMC
+$26.6M
5
USB icon
US Bancorp
USB
+$24.5M

Sector Composition

Rank Sector Weight
1 Technology 22.34%
2 Financials 15.19%
3 Healthcare 14.9%
4 Industrials 14.61%
5 Consumer Discretionary 10.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
51
Merck
MRK
$321B
$89.9M 0.64%
681,543
-86,608
-11% -$10.7M
COP icon
52
ConocoPhillips
COP
$145B
$88.8M 0.63%
698,055
-4,330
-0.6% -$494K
LECO icon
53
Lincoln Electric
LECO
$13.7B
$88.3M 0.63%
345,731
-15,906
-4% -$3.76M
CINF icon
54
Cincinnati Financial
CINF
$26.8B
$87.3M 0.62%
702,762
+443,024
+171% +$50M
TROW icon
55
T. Rowe Price
TROW
$25.6B
$83.5M 0.6%
685,047
-10,679
-2% -$1.19M
IBOC icon
56
International Bancshares
IBOC
$4.75B
$81.9M 0.58%
1,458,098
+437,592
+43% +$23.2M
ADI icon
57
Analog Devices
ADI
$179B
$81.3M 0.58%
411,135
+28,995
+8% +$5.57M
BJ icon
58
BJs Wholesale Club
BJ
$12.6B
$81M 0.58%
1,070,381
-3,265
-0.3% -$228K
CVCO icon
59
Cavco Industries
CVCO
$4.33B
$77.6M 0.55%
194,505
-1,399
-0.7% -$495K
NDSN icon
60
Nordson
NDSN
$16.4B
$76M 0.54%
276,925
+4,112
+2% +$1.07M
SLGN icon
61
Silgan Holdings
SLGN
$4.34B
$75.9M 0.54%
1,562,098
-4,350
-0.3% -$193K
XOM icon
62
ExxonMobil
XOM
$651B
$74.3M 0.53%
639,076
-13,532
-2% -$1.42M
GWW icon
63
W.W. Grainger
GWW
$64B
$73.9M 0.53%
72,618
-1,663
-2% -$1.55M
LFUS icon
64
Littelfuse
LFUS
$11.2B
$73.7M 0.53%
304,145
+87,719
+41% +$21.1M
SFM icon
65
Sprouts Farmers Market
SFM
$8.17B
$73.3M 0.52%
1,137,111
-340,230
-23% -$19M
CRVL icon
66
CorVel
CRVL
$3.03B
$73.3M 0.52%
836,103
-6,003
-0.7% -$483K
FELE icon
67
Franklin Electric
FELE
$4.57B
$71.3M 0.51%
667,992
+162,689
+32% +$16.1M
CNS icon
68
Cohen & Steers
CNS
$4.19B
$71.3M 0.51%
927,837
-3,973
-0.4% -$284K
APD icon
69
Air Products & Chemicals
APD
$66.8B
$71.1M 0.51%
293,521
-4,242
-1% -$1.04M
WTS icon
70
Watts Water Technologies
WTS
$11.5B
$70.6M 0.5%
332,019
+67,581
+26% +$13.7M
IDCC icon
71
InterDigital
IDCC
$7.84B
$67.5M 0.48%
633,965
-4,389
-0.7% -$464K
SBUX icon
72
Starbucks
SBUX
$121B
$67.1M 0.48%
733,711
+49,116
+7% +$4.57M
ADBE icon
73
Adobe
ADBE
$98.5B
$66.9M 0.48%
132,621
-465
-0.3% -$267K
MZTI
74
The Marzetti Company
MZTI
$2.95B
$65.7M 0.47%
316,561
-2,805
-0.9% -$534K
CHKP icon
75
Check Point Software Technologies
CHKP
$13.1B
$65.6M 0.47%
400,160
+93,959
+31% +$15.1M

Similar funds

Boston Trust Walden's Q1 2024 Portfolio in Review

As of Q1 2024, Boston Trust Walden held 386 positions worth $14B, up 5.8% from $13.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Trust Walden's Q1 2024 filing shows 14 new, 92 increased, 193 reduced and 14 closed positions. Its largest new stake was Magnolia Oil & Gas: 2,134,546 shares worth $55.4M. The largest sale was Medpace, an estimated $77.8M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q1 2024 buy was Magnolia Oil & Gas: 2,134,546 shares worth $55.4M.
  • Boston Trust Walden added most to Cincinnati Financial in Q1 2024, an estimated $50M increase.
  • Boston Trust Walden's biggest Q1 2024 reduction was Medpace, cutting an estimated $77.8M.
  • Boston Trust Walden fully exited PHYSICIANS REALTY TRUST in Q1 2024, selling an estimated $62.5M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $14B portfolio in Q1 2024.
  • Boston Trust Walden opened 14 new positions and closed 14 in Q1 2024.
  • Boston Trust Walden's portfolio value rose 5.8% quarter-over-quarter to $14B.

Based on Boston Trust Walden's 13F filing for Q1 2024, filed 22 Apr 2024.